HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Net Revenue Management - Are You Leaving Money On The Table?

Consumer health players risk missing deserved revenue and profits by failing to take a holistic approach to net revenue management. In this exclusive interview, Simon-Kucher & Partners’ Josh Goodman explains how effective NRM can have a big impact on sales and profits by ensuring full capture of willingness to pay, maximizing promotion ROI, incentivizing beneficial trade terms, prioritizing appropriate channel presence, and capturing all relevant customer purchase occasions. Goodman offers his top tips for small NRM hygiene factors that can make a big difference.

Business Strategies Pricing Strategies Market Intelligence

Probe Into GSK/Pfizer Consumer Tie-up Launched By Australian Competition Watchdog

Assessing how closely GSK's brands such as Panadol compete with Pfizer brands like Robitussin is the aim of an investigation launched by Australia's Competition and Consumer Commission into the pharma giants' proposed consumer health joint venture. 
Deals Regulation OTC Drugs

Perrigo Lights Smoking Cessation For Growth With Turnaround Woes 'Fixable'

As "market leader" in OTC nicotine replacement treatments, Perrigo should "be the one that's doing a lot of innovation," says CEO Murray Kessler. He discussed Perrigo's problems and potential sales drivers as it reported 2018 net sales of $4.7bn, down 4% , and Q4 net sales of $1.2bn, down 7%. Global consumer health product sales for year were flat at $3.9bn and Q4 sales were down 4% at $973m.

International Europe South America

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

Zentiva Set To Acquire Romania's Solacium

Zentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company, entering into a shared purchase agreement with Siyiara to acquire Romania-based food supplement and OTC medicines producer Solacium.
Deals Romania

Teva Licenses OTC And Cosmetics Portfolio To Trimb In Scandinavia

Trimb has gained the exclusive rights from Teva to market across Scandinavia a portfolio of "well-known" consumer health brands, covering skin-care, oral-care, and digestive health, as well as dietary supplements. 
Deals Sweden

Dermapharm Expands International Herbals And Supplements Capacity With Two Acquisitions

German generics and OTC specialist Dermapharm has snapped up two firms that it said would enable it to boost its international presence. 
Health OTC Drugs
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

Providing High Value, OTC Drugs Deserve Higher Profile In Health Care – CHPA

While Rx drug pricing is under attack by Congress, White House and consumer and public health advocacy groups, OTC drugs' value isn't gaining a higher profile. "Our health care system undervalues the contribution of our industry's products," says CHPA chief Scott Melville. Trade group conducts “Value of OTC Medicines" study for reasons including raising the profile of consumer health products in the US health care system.

Health Wellness

Zur Rose Steams Ahead With Acquisition-Led Expansion Amid Investor Concerns

Zur Rose adds French online retail platform Doctipharma as two board members resign over “differences of opinion” with regards to the firm's growth strategy.

Health Business Strategies

SPF Testing Costs (And Variability) Could Be Reduced With In Vitro Method Uptake

Cosmetics Europe expects its in vitro method for SPF determination to be a published ISO standard within two to three years. The European Commission is behind in vitro sunscreen testing, and the method could significantly reduce costs and technical challenges while providing in vivo-equivalent results, the trade group says.

Beauty Standards
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Bayer Bullish On Consumer Health’s Prospects Despite ‘Challenging’ 2018

Notwithstanding a particularly difficult 2018, Bayer Consumer Health still has "one of the best brand portfolios," and can continue to compete with the market leaders, says CEO Werner Baumann. Consumer Health struggled particularly in the US and Europe in the 12 months, with the majority of its leading brands recording poor performances.
Sales & Earnings Business Strategies

Reckitt ‘Not Happy’ With Consumer Health Growth In 2018, Following European And Infant Nutrition Woes

RB's Health business failed to keep pace with market growth in 2018, with the firm admitting its mindset in Europe "needs to change." The UK-based consumer-goods giant spent the 12 months working on its RB 2.0 restructuring program, which will give it the option to separate into two independent companies focusing on Health and Hygiene by 2020.
Sales & Earnings Business Strategies

France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot

France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.
France Market Intelligence
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

Biotene OTC Dry Mouth Competitor Remains On Market As GSK Litigates

Former Biotene owner Laclede ordered by federal judge to stop using brand, now owned by GSK, to promote its competing line of Salivea dry mouth products. But judge rejected GSK’s request that the Salivea dry mouth product marketers are subject to a lifetime non-compete agreement.

Commercial OTC Drugs

J&J CEO Sees Victory Ahead On Talc, Growth From Johnson's Relaunch

JP Morgan analysts had questions and J&J CEO Alex Gorsky and CFO Joseph Wolk had answers about liability suits alleging that use of the Johnson's brand talcum powder has caused mesothelioma or ovarian cancer. On the Johnson's brand outlook following its relaunch as a natural product line, Gorsky says sales were a key driver in the firm's consumer health sales in the 2018 third quarter. China, meanwhile, is a model for growing sales online, he says.
Legal Issues Ingredients

Keystone Labs Court-Ordered To Halt OTC Drug Manufacturing; Cosmetics Not Affected, It Says

Keystone Labs agrees to cease manufacturing OTC drugs following a 2013 FDA warning letter and repeated GMP violations noted during inspections, including failure to investigate sources of contamination. Firm suggests it will continue making cosmetic hair- and skin-care formulas while outsourcing OTC product manufacturing.

Legal Issues Manufacturing
See All
UsernamePublicRestriction

Register